Radiate Holdco, LLC Releases Second Quarter 2025 Financial Results
PRINCETON, N.J., Aug. 14, 2025 /PRNewswire/ — Radiate Holdco, LLC (“Radiate”) announced today that it released its Second Quarter 2025 financial... Read more.
Innovative Eyewear Inc. Reports Q2 2025 Unaudited Financial Results
Revenue Surged 88% in Q2 2025 vs. Q2 2024 MIAMI, Aug. 14, 2025 /PRNewswire/ — Innovative Eyewear Inc., (NASDAQ: LUCY, LUCYW), the developer of smart eyewear... Read more.
BIT Mining Limited Announces Unaudited Financial Results for the Six Months Ended June 30, 2025
AKRON, Ohio, Aug. 14, 2025 /PRNewswire/ — BIT Mining Limited (NYSE: BTCM) (“BIT Mining,” “the Company,” “we,” “us,”... Read more.
Essa Pharma Inc. Announces Ex-Dividend Date and Nasdaq Due Bill Trading for Previously Announced Cash Distribution
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Aug. 14, 2025 /PRNewswire/ — ESSA Pharma Inc. (“ESSA,” or the “Company“) (NASDAQ: EPIX)... Read more.
Cboe Global Markets Declares Increased Third-Quarter 2025 Dividend
Quarterly cash dividend increased 14 percent to $0.72 per share 15th consecutive year Cboe has increased its dividend CHICAGO, Aug. 14, 2025 /PRNewswire/ — Cboe... Read more.
Freckie Capital Enters US Market to Redefine Intelligent Investing Through Strategic Thinking
DENVER, Aug. 14, 2025 /PRNewswire/ — Intelligent wealth management platform Freckie Capital today announced its official entry into the United States, marking... Read more.
Globant Reports 2025 Second Quarter Financial Results
LUXEMBOURG, Aug. 14, 2025 /PRNewswire/ — Globant (NYSE: GLOB) today announced results for the three months ended June 30, 2025. “This quarter, we continued... Read more.
KORE Reports Second Quarter 2025 Results
Growth in Revenue, Adjusted EBITDA, Connections, and Free Cash Flow ATLANTA, Aug. 14, 2025 /PRNewswire/ — KORE Group Holdings, Inc. (NYSE: KORE) (“KORE”... Read more.
CME Group Opens Registration for 22nd Annual Global University Trading Challenge
CHICAGO, Aug. 14, 2025 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that registration for the 22nd annual CME... Read more.
TuHURA Biosciences, Inc. Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
Completed the acquisition of Kineta, Inc. and its VISTA inhibiting monoclonal antibody (mAb), now named “TBS-2025;” planning to initiate a Phase 2 trial... Read more.